Oncology Times - Ot Broadcasts From The Ipad Archives
The Disappointment of the NSABP C-08 Trial
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:09:05
- Mas informaciones
Informações:
Sinopsis
Norman Wolmark on the study's frustrating but unequivocal results showing that bevacizumab did not extend disease-free survival in adjuvant therapy for early colon cancer at 3 years, even though there had been a benefit at 1 year. Also weighing in: Nicholas Petrelli
